Sino Biological Finalizes the Acquisition of SignalChem Biotech, Strengthening Global Presence and Expanding Product Portfolio
26 Abril 2024 - 1:25PM
via NewMediaWire -- Sino Biological, Inc.("Sino
Biological" or the "Company”), a biotechnology company listed on
the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047),
specializing in biological research reagents and related
technical contract research services, has successfully
concluded its acquisition of Vancouver-based Canadian biotechnology
company SignalChem Biotech Inc. (“SCB” or "SignalChem”). Sino
Biological has acquired 100% of SCB shares in a deal valued at $48M
USD, inclusive of all assets, assumed indebtedness, and net of cash
deposits.
SignalChem Biotech Inc. is renowned for its
specialized bioactive enzymes, including kinases, proteases,
phosphatases, ubiquitin and epigenetic enzymes. Over the past two
decades, SCB has established proprietary production and quality
control platforms, setting industry standards for the development
and production of high-quality bioactive enzyme proteins to support
scientists from basic research through drug discovery and
development. Now operating as a wholly-owned subsidiary of Sino
Biological, SCB will bring exclusive expertise in enzyme production
to the company’s existing technology platforms.
The strategic synergy between Sino Biological and
SignalChem enables the provision of a broader range of products and
research services, supporting the wider life sciences community and
facilitating the discovery and development of novel treatments,
vaccines and diagnostic platforms.
“SignalChem is at the scientific forefront of
enzyme bioreagent development and production, as well as
enzyme-based compound screening technologies. The acquisition
of SCB further strengthens Sino Biological’s robust presence in
bioactive recombinant proteins and related contract research
services,” stated Dr. Jie Zhang, Sino Biological’s President and
General Manager.
"We are excited to join forces with Sino
Biological and embark on this new chapter of growth and
collaboration," said Mr. Jun Yan, co-founder, President and CEO of
SignalChem Biotech. "Together, we have a unique opportunity to
leverage our complementary strengths and resources to accelerate
innovation and better serve the scientific community. We look
forward to combining our expertise to develop novel solutions that
address the complex challenges facing researchers around the
world.”
Sino Biological remains committed to maintaining
the high standards of quality, reliability, and customer
satisfaction throughout the integration process. Customers can
expect continued access to the same high-quality products and
services they have come to rely on, backed by the combined
expertise and resources of Sino Biological and SignalChem
Biotech.
About Sino Biological
Sino Biological is an international reagent
supplier and contract research service provider. The company
specializes in recombinant protein production and antibody
development. All of Sino Biological's products are independently
developed and produced with a stringent quality management system,
and include unique bioreagents addressing areas such as cell
therapy, stem cell, and infectious disease research. For
example, Sino Biological has a wealth of viral antigens (Provir®)
and corresponding antibodies, with one of the world’s extensive
collections. Sino Biological is also a well-recognized, qualified
source of recombinant cytokines and
high-quality GMP-grade cytokines. In addition, Sino Biological
offers contract research production services for the custom
development of full length, bioactive proteins and high-affinity
antibodies, along with other services. To learn more about Sino
Biological visit www.sinobiological.com, follow us
on LinkedIn or @SinoInc on Twitter.
About SignalChem Biotech Inc.
SignalChem Biotech Inc. is a biotech company
focused on the research, development and production of innovative
and high-quality human recombinant cell signaling products.
Throughout the years, SignalChem has capitalized on its core
expertise in cellular signaling, molecular biology and protein
biochemistry to generate more than 2,000 functional protein
products. SignalChem strives to support scientists in academia,
pharma and biotech companies around the world by creating effective
research tools to advance the basic research in life sciences and
to facilitate the efforts in drug discovery and development. For
more information, please visit www.signalchem.com.
Forward-Looking Statements
Certain statements in this document are
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act. These statements are based on
Sino Biological and SCB management's current expectations and are
subject to uncertainty and changes in circumstances. Actual results
may differ materially from those included in these statements due
to a variety of factors, over which neither Sino Biological nor SCB
has control. Sino Biological and SCB assume no obligation to update
these forward-looking statements and do not intend to do so.
Contacts:
Sino Biological,
Inc.gmo@sinobiological.cnwww.sinobiological.com